For lung cancer samples, the base OncoPro medium formulation was supplemented with HS FGF-10, while medium for breast and endometrial cancer tumoroids was supplemented with HS FGF-10 and beta-estradiol (Supplementary Table S1). The gene discussed is FGF10; the disease is endometrial cancer.